• About PRIME
  • Advertise With Us
  • Contact Us
Advertisement
PRIME Journal
  • Home
  • Digital Issue
  • Categories
    • Energy Based Devices
    • Minimally Invasive
    • Skincare
    • Injectables
    • Dermatology
    • Anti-ageing
    • Body Contouring
    • Invasive treatments
  • Features
    • Case Study
    • PRIME People
    • Company Profile
    • Industry Analysis
    • Sponsored Features
  • News
  • Sign Up

Select Page
Advertisement

PRIME July/August 2023

Digital Magazine, News

Share:

PreviousA non-invasive approach for jawline contouring
NextPRIME September/October 2023 issue

Related Posts

Janssen announces U.S. FDA approval Of STELARA® (ustekinumab) for the treatment of adolescents with moderate to severe plaque psoriasis

Janssen announces U.S. FDA approval Of STELARA® (ustekinumab) for the treatment of adolescents with moderate to severe plaque psoriasis

October 20, 2017

<strong>Cosmetic Surgery Safety Conference</strong>

Cosmetic Surgery Safety Conference

November 20, 2022

FACE 2020 announces​​ new business agenda sessions

FACE 2020 announces​​ new business agenda sessions

January 30, 2020

Galderma receives FDA approval of novel treatment option for rosacea patients

Galderma receives FDA approval of novel treatment option for rosacea patients

December 24, 2014

Search

Login Status

Forgot?  Register

May/June 2026 Issue

Advertisement

Upcoming Events

No events are found.

All events

Categories

  • Injectables
  • Dermatology
  • Anti-ageing
  • Body Contouring
  • Invasive treatments
  • Case Study
  • Practice Management
  • Sponsored
  • Industry Insider
  • Company Profile
  • PRIME People
  • Meeting reviews
  • Commentary

Designed by Elegant Themes | Powered by WordPress

  • Contact Us
  • Editorial Board
  • Terms & Conditions
  • Privacy Policy